ANG003

· Anagram Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ANG003, covering 2024-08-13 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Assess Safety and Efficacy of ANG003 [Phase 1]